220 related articles for article (PubMed ID: 38212334)
1. Cryo-EM observation of the amyloid key structure of polymorphic TDP-43 amyloid fibrils.
Sharma K; Stockert F; Shenoy J; Berbon M; Abdul-Shukkoor MB; Habenstein B; Loquet A; Schmidt M; Fändrich M
Nat Commun; 2024 Jan; 15(1):486. PubMed ID: 38212334
[TBL] [Abstract][Full Text] [Related]
2. Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43.
Li Q; Babinchak WM; Surewicz WK
Nat Commun; 2021 Mar; 12(1):1620. PubMed ID: 33712624
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 skeins show properties of amyloid in a subset of ALS cases.
Robinson JL; Geser F; Stieber A; Umoh M; Kwong LK; Van Deerlin VM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2013 Jan; 125(1):121-31. PubMed ID: 23124365
[TBL] [Abstract][Full Text] [Related]
4. Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43.
Jiang YX; Cao Q; Sawaya MR; Abskharon R; Ge P; DeTure M; Dickson DW; Fu JY; Ogorzalek Loo RR; Loo JA; Eisenberg DS
Nature; 2022 May; 605(7909):304-309. PubMed ID: 35344984
[TBL] [Abstract][Full Text] [Related]
5. Structure of pathological TDP-43 filaments from ALS with FTLD.
Arseni D; Hasegawa M; Murzin AG; Kametani F; Arai M; Yoshida M; Ryskeldi-Falcon B
Nature; 2022 Jan; 601(7891):139-143. PubMed ID: 34880495
[TBL] [Abstract][Full Text] [Related]
6. Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage.
Kumar ST; Nazarov S; Porta S; Maharjan N; Cendrowska U; Kabani M; Finamore F; Xu Y; Lee VM; Lashuel HA
Nat Neurosci; 2023 Jun; 26(6):983-996. PubMed ID: 37248338
[TBL] [Abstract][Full Text] [Related]
7. The truncated C-terminal RNA recognition motif of TDP-43 protein plays a key role in forming proteinaceous aggregates.
Wang YT; Kuo PH; Chiang CH; Liang JR; Chen YR; Wang S; Shen JC; Yuan HS
J Biol Chem; 2013 Mar; 288(13):9049-57. PubMed ID: 23372158
[TBL] [Abstract][Full Text] [Related]
8. Detection of TDP-43 oligomers in frontotemporal lobar degeneration-TDP.
Kao PF; Chen YR; Liu XB; DeCarli C; Seeley WW; Jin LW
Ann Neurol; 2015 Aug; 78(2):211-21. PubMed ID: 25921485
[TBL] [Abstract][Full Text] [Related]
9. Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions.
Mompeán M; Romano V; Pantoja-Uceda D; Stuani C; Baralle FE; Buratti E; Laurents DV
J Biol Chem; 2017 Jul; 292(28):11992-12006. PubMed ID: 28566288
[TBL] [Abstract][Full Text] [Related]
10. Biophysical Studies of LLPS and Aggregation of TDP-43 LCD.
Babinchak WM; Surewicz WK
Methods Mol Biol; 2023; 2551():497-513. PubMed ID: 36310222
[TBL] [Abstract][Full Text] [Related]
11. Cryo-EM structures of four polymorphic TDP-43 amyloid cores.
Cao Q; Boyer DR; Sawaya MR; Ge P; Eisenberg DS
Nat Struct Mol Biol; 2019 Jul; 26(7):619-627. PubMed ID: 31235914
[TBL] [Abstract][Full Text] [Related]
12. An
Cascella R; Banchelli M; Abolghasem Ghadami S; Ami D; Gagliani MC; Bigi A; Staderini T; Tampellini D; Cortese K; Cecchi C; Natalello A; Adibi H; Matteini P; Chiti F
Ann Med; 2023 Dec; 55(1):72-88. PubMed ID: 36495262
[No Abstract] [Full Text] [Related]
13. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.
Geser F; Lee VM; Trojanowski JQ
Neuropathology; 2010 Apr; 30(2):103-12. PubMed ID: 20102519
[TBL] [Abstract][Full Text] [Related]
14. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
15. Atomistic Insights into A315E Mutation-Enhanced Pathogenicity of TDP-43 Core Fibrils.
Li F; Chen Y; Liu X; Tang Y; Dong X; Wei G
ACS Chem Neurosci; 2022 Sep; 13(18):2743-2754. PubMed ID: 36053560
[TBL] [Abstract][Full Text] [Related]
16. Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases.
Chang A; Xiang X; Wang J; Lee C; Arakhamia T; Simjanoska M; Wang C; Carlomagno Y; Zhang G; Dhingra S; Thierry M; Perneel J; Heeman B; Forgrave LM; DeTure M; DeMarco ML; Cook CN; Rademakers R; Dickson DW; Petrucelli L; Stowell MHB; Mackenzie IRA; Fitzpatrick AWP
Cell; 2022 Apr; 185(8):1346-1355.e15. PubMed ID: 35247328
[TBL] [Abstract][Full Text] [Related]
17. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
[TBL] [Abstract][Full Text] [Related]
18. Full-length TDP-43 and its C-terminal domain form filaments
Capitini C; Fani G; Vivoli Vega M; Penco A; Canale C; Cabrita LD; Calamai M; Christodoulou J; Relini A; Chiti F
Amyloid; 2021 Mar; 28(1):56-65. PubMed ID: 33026249
[TBL] [Abstract][Full Text] [Related]
19. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration.
Nishimura AL; Zupunski V; Troakes C; Kathe C; Fratta P; Howell M; Gallo JM; Hortobágyi T; Shaw CE; Rogelj B
Brain; 2010 Jun; 133(Pt 6):1763-71. PubMed ID: 20472655
[TBL] [Abstract][Full Text] [Related]
20. Computationally Designed Molecules Modulate ALS-Related Amyloidogenic TDP-43
Liu X; Duan S; Jin Y; Walker E; Tsao M; Jang JH; Chen Z; Singh AK; Cantrell KL; Ingolfsson HI; Buratto SK; Bowers MT
ACS Chem Neurosci; 2023 Dec; 14(24):4395-4408. PubMed ID: 38050862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
